Patients with a type of advanced skin cancer have a new treatment option as pembrolizumab, also known as Keytruda, has been recommended for use on the Cancer Drugs Fund.
NICE has recommended a pioneering cancer treatment, CART-cell therapy, for people under the age of 25 with leukaemia.
Matthew Parris, Healthwatch deputy CEO, shares his experience of visiting care homes with Healthwatch Surrey
Funding available to academics and researchers to develop new methods and techniques for diagnostic technologies
Following improved access and optimisation of the website, the NICE guidance app will no longer be available for download with plans to phase it out by January 2019.
NICE has announced the appointment of Jeanette Kusel as director for NICE Scientific Advice.
Natasha Sloman, head of Hospital Inspection at the Care Quality Commission (CQC), discusses how working with NICE has been fundamental in making her work a success
Paige Ataou shares her experience of mental health in the changing world and talks about environment and relationships
Women should be offered the treatment option of their choice, in discussion with their clinician
Katie Currie, public health principal, outlines how the NICE Scholar programme shaped her career development
Nageena Khalique QC, barrister and chair of the committee for the NICE guideline on Decision making and mental capacity, discusses how the new guideline applies to a range of situations
Dialysis choice allows patients to live the life they want to
People who incorrectly believe they are allergic to penicillin are unnecessarily put at an increased risk of developing MRSA or C difficile, NICE warns today.
The 2019 Shared Learning Awards are now open for entries.
A new NICE quality standard (QS) on eating disorders focuses on promoting early access and coordinating care between services.
Driver training and car sharing should also be considered in bid to reduce emissions
CAR-T is too expensive to recommend as a treatment for adults with lymphoma, NICE says in draft guidance today (19 September).
Dr Julia Terry discussed how her experience as a NICE Fellow enhanced her academic career
Hundreds of patients with a type of advanced skin cancer are set to benefit from a new treatment, dabrafenib plus trametinib.
Dr Finnikin explains how he approaches patients about cardiovascular risk and changes to lifestyle
Procedure could be an option for adults with severe asthma whose symptoms cannot be adequately controlled with drugs
CAR-T considered to be an exciting innovation which can cure some patients but very expensive
People should take honey or cough medicines instead but speak to their GP if it persists for longer than three weeks
NICE hopes for further talks over nusinersen for treating a rare genetic disorder; spinal muscular atrophy (SMA).
Naomi introduces the NICE into Action webinar series and tells us why this is important for the allied health professions.
NICE has published a draft guideline on the care and support adults with cerebral palsy should receive.
Eleanor describes how a new system to comment on draft guidance will better support NICE stakeholders and staff during consultations
A new master’s degree in healthcare decision making has been launched by London School of Economics and Political Science (LSE) in collaboration with NICE.
Around 60% of children with high-risk neuroblastoma could be treated with dinutuximab beta
Hundreds of patients a year set to benefit from roll out of dye to all of England’s neurosurgical units
A major collaboration between NICE and Greater Manchester has been secured for a further three years, until June 2021.
Sundus Jawad, tells us how improving hydration in care homes reduces the risk of urinary tract infections (UTIs) for residents
Emily tells us how a ground-breaking HERCULES project will help NICE to get the evidence we need faster.
Laura McNeillie picks up NICE award at Chief Allied Health Professions Officer’s awards
NICE has updated its guidance for the support of people living with dementia.
Deyo tells us how the NICE multimorbidity guideline is helping him to help his patients.
Women with a type of early breast cancer may not benefit from continuing or starting a drug after having surgery, NICE says in draft guidance.
Fiona invites us to join her at NICE’s social care data jam
Celia introduces the topic of clinical improvement and discusses how it affects changes in the NHS
People who have suffered trauma and are at risk of post-traumatic stress disorder (PTSD) should be offered therapy within one month, NICE says in new draft guidance.
David has been honoured in Her Majesty, the Queen’s birthday honours list to recognise his outstanding achievements in NHS Leadership.
NICE Scientific Advice (NSA) launched a new health economic model review service, PRIMA, in December 2017 and it is already proving to be a valuable resource for model developers.
NICE says more people should be able to freely access pembrolizumab, known as Keytruda, after a new trial shows it helps certain adults with lung cancer live more than a year longer.
Victoria Hilton and her team, finalists of the NICE Shared Learning Awards, tell us about an improved care pathway to support better outcomes for patients with gastrointestinal problems
Jason tells us why winning a prestigious Skills for Care award matters to him and his team
Reductions to the price of three multiple sclerosis (MS) drugs mean NICE is now able to recommend them for routine NHS funding.
The Food First team, finalists of the NICE Shared Learning Awards, tell us about their approach to improving nutritional care in care homes
NICE has published new guidance to help healthcare professionals optimise the treatment of urinary tract infections (UTIs).
NICE has recommended three blood cancer drugs, brentuximab vedotin, midostaurin and arsenic trioxide be made available on the NHS.
NICE has published draft guidance in which dinutuximab beta is not recommended as a treatment for high-risk neuroblastoma – a rare type of cancer that mainly affects children and young people.